- Home
- PCRX vs MPB Comparison
PCRX vs MPB Comparison
Compare PCRX & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MPB
- Stock Information
- Founded
- PCRX 2006
- MPB 1868
- Country
- PCRX United States
- MPB United States
- Employees
- PCRX N/A
- MPB N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- PCRX Health Care
- MPB Finance
- Exchange
- PCRX Nasdaq
- MPB Nasdaq
- Market Cap
- PCRX 604.7M
- MPB 513.4M
- IPO Year
- PCRX 2011
- MPB N/A
- Fundamental
- Price
- PCRX $16.52
- MPB $31.62
- Analyst Decision
- PCRX Buy
- MPB Buy
- Analyst Count
- PCRX 10
- MPB 3
- Target Price
- PCRX $26.60
- MPB $32.67
- AVG Volume (30 Days)
- PCRX 545.3K
- MPB 90.6K
- Earning Date
- PCRX 11-06-2024
- MPB 10-23-2024
- Dividend Yield
- PCRX N/A
- MPB 2.53%
- EPS Growth
- PCRX N/A
- MPB 14.41
- EPS
- PCRX N/A
- MPB 2.91
- Revenue
- PCRX $694,957,000.00
- MPB $173,416,000.00
- Revenue This Year
- PCRX $4.59
- MPB N/A
- Revenue Next Year
- PCRX N/A
- MPB $19.64
- P/E Ratio
- PCRX N/A
- MPB $10.88
- Revenue Growth
- PCRX 4.40
- MPB 4.93
- 52 Week Low
- PCRX $11.16
- MPB $19.20
- 52 Week High
- PCRX $35.95
- MPB $33.23
- Technical
- Relative Strength Index (RSI)
- PCRX 44.28
- MPB 52.02
- Support Level
- PCRX $16.11
- MPB $29.88
- Resistance Level
- PCRX $18.34
- MPB $33.23
- Average True Range (ATR)
- PCRX 0.83
- MPB 0.98
- MACD
- PCRX -0.17
- MPB -0.03
- Stochastic Oscillator
- PCRX 5.33
- MPB 51.94
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.